Black Diamond Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Black Diamond Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Black Diamond Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Black Diamond Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Black Diamond Therapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Black Diamond Therapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Mark A Velleca, M.D., Ph.D.
Chief Executive Officer; President; Chairman Executive BoardMr. Mark A Velleca has been the Chief Executive Officer, President and Chairman of the company since September 2023. Prior to this, he served as the Chief Executive Officer at G1 Therapeutics Inc. Previously, he served as the Senior Vice President at CGI Pharmaceuticals, Inc and as the Executive Vice President at The Leukemia & Lymphoma Society.
Brent Hatzis Schoch
Chief Operating Officer; General Counsel Senior ManagementMr. Brent Hatzis Schoch has been the Chief Operating Officer and General Counsel of the company since 2019. Prior to this, he served as the Senior Vice President, General Counsel and Corporate Secretary at Radius Health Inc. Previously, he served as the Senior Vice President and Chief Legal Counsel at Merz Pharma GmbH & Co KGaA.
Sergey Yurasov, MD, PhD
Chief Medical Officer Senior ManagementMr. Sergey Yurasov has been the Chief Medical Officer of the company since 2022. Prior to this, he served as the Chief Medical Officer at Nuvation Bio. Mr. Previously, he served as the Chief Medical Officer and Senior Vice President of Clinical Development at Immune DesignCorp.He also served as the Senior Vice President of Clinical Development at Clovis Oncology.
Elizabeth Buck, PhD
Chief Scientific Officer; Co-Founder Senior ManagementMs. Elizabeth Buck has been the Chief Scientific Officer and Co-Founder of the company since 2021. Prior to this, she served as the Assistant Director of Advanced Preclinical Pharmacology at OSI Pharmaceuticals. Ms. Buck also served as the Global Director of Resource Management at IQVIA Consulting Services and as a Senior Manager at Boston Scientific Corporation.
Melanie Morrison
Chief Development Officer Senior ManagementMs. Melanie Morrison has been the Chief Development Officer of the company since June 2023. Prior to this, she served as a Senior Vice President, Development Operations of the company from 2022 to 2023. Previously, she served as the Senior Vice President, Program Management and Clinical Operations at Nuvation Bio and in various other roles at Aduro Biotech, Immune Design, and Medivation.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer